Related Experiment Video
Updated: Dec 8, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time
Lauren Lapointe-Shaw1,2,3,4, Hannah Chung3, Beate Sander2,3,4,5,6
1Department of Medicine, University of Toronto, Toronto, ON, Canada.
Insights
Many individuals with Hepatitis C virus (HCV) infection are diagnosed late, near complications. This study found a rising trend in late diagnoses, emphasizing the need for expanded HCV screening.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) is a treatable cause of liver cirrhosis, but many patients are diagnosed late.
- Late diagnosis delays treatment and increases the risk of severe liver disease complications.
Purpose of the Study:
- To determine the frequency of diagnosing Hepatitis C virus (HCV) infection within six months of advanced liver disease complications.
- To identify risk factors associated with this peri-complication diagnosis pattern.
Main Methods:
- Retrospective cohort study of 39,515 Ontario residents diagnosed with chronic HCV infection (2003-2014).
- Defined peri-complication diagnosis as advanced liver disease complication (cirrhosis, HCC, transplant) within ±6 months of HCV diagnosis.
- Used multivariable logistic regression to identify risk factors for peri-complication diagnosis.
Main Results:
- 4.2% of all HCV-diagnosed patients (1645/39,515) received a peri-complication diagnosis.
- Peri-complication diagnoses increased over the study period.
- Risk factors included older age, alcohol use, diabetes, HBV co-infection, and high morbidity; female sex, immigrant status, and prior healthcare visits were protective.
Conclusions:
- Over a quarter of HCV patients with complications were diagnosed peri-complication.
- The increasing trend highlights a critical gap in timely HCV diagnosis and the need for enhanced screening strategies.
Background & Aims:
Hepatitis C virus (HCV) is a common and treatable cause of cirrhosis and its complications, yet many chronically infected individuals remain undiagnosed until a late stage. We sought to identify the frequency of and risk factors for HCV diagnosis peri-complication, that is within six months of an advanced liver disease complication.
Methods:
This was a retrospective cohort study of Ontario residents diagnosed with chronic HCV infection between 2003 and 2014. HCV diagnosis peri-complication was defined as the occurrence of decompensated cirrhosis, hepatocellular carcinoma or liver transplant within ±6 months of HCV diagnosis. Multivariable logistic regression was used to identify risk factors for peri-complication diagnosis among all those diagnosed with HCV infection.
Results:
Our cohort included 39,515 patients with chronic HCV infection, of whom 4.2% (n = 1645) were diagnosed peri-complication; these represented 31.6% of the 5,202 patients who developed complications in the follow-up period. Peri-complication diagnosis became more common over the study period and was associated with increasing age among baby boomers, alcohol use, diabetes mellitus, chronic HBV co-infection and moderate to high levels of morbidity. Female sex, immigrant status, having more previous outpatient physician visits, a previous emergency department visit, a history of drug use or mental health visits were associated with reduced risk of peri-complication diagnosis.
Conclusions:
Over a quarter of HCV-infected patients with complications were diagnosed peri-complication. This problem increased over time, suggesting a need to further expand HCV screening.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

